SPR Therapeutics Awarded $6M Contract From the United States Department of Defense to Advance Non-Opioid Pain Relief Therapy
May 15, 2017 09:03 ET
|
SPR Therapeutics, LLC
CLEVELAND, May 15, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics (SPR) has been awarded a $6M four-year contract from the U.S. Department of Defense (DoD) to further advance its SPRINT™ Peripheral Nerve...
Les C. Vinney Named 2016 NACD Top 100 Directors
January 19, 2017 09:30 ET
|
SPR Therapeutics, LLC
CLEVELAND, Jan. 19, 2017 (GLOBE NEWSWIRE) -- The National Association of Corporate Directors (NACD) has named SPR® Therapeutics’ Board Member, Les C. Vinney, one of the top 100 most influential...
SPR Therapeutics Names Dave Youngberg Vice President of Sales
January 17, 2017 09:30 ET
|
SPR Therapeutics, LLC
CLEVELAND, Jan. 17, 2017 (GLOBE NEWSWIRE) -- SPR® Therapeutics announced today that industry veteran, Dave Youngberg, has joined the neurostimulation company as Vice President of Sales. ...
Neuromodulation Market - Forecasts to 2017
October 23, 2013 11:14 ET
|
Research and Markets
Dublin, Oct. 23, 2013 (GLOBE NEWSWIRE) -- Research and Markets
(http://www.researchandmarkets.com/research/33dhcm/neuromodulation)
has announced the addition of the
"Neuromodulation...
Neuronetics, Inc. Raises $30 Million in Series E Financing
May 16, 2011 08:30 ET
|
Neuronetics
MALVERN, PA--(Marketwire - May 16, 2011) - Neuronetics, Inc., maker of the NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy® System for the treatment of major depression*, announced today...
New Trial Data Confirm Clinical Effectiveness and Good Adherence Rates With NeuroStar TMS Therapy in Patients With Major Depressive Disorder Treated in a Real World Practice Setting
May 15, 2011 19:00 ET
|
Neuronetics
HONOLULU, HI--(Marketwire - May 15, 2011) - Results of a Neuronetics-sponsored, multisite observational study of patients with major depressive disorder (MDD) treated with Neuronetics' NeuroStar...
Neuronetics Receives TiE50 Award for Technology Entrepreneurship
May 09, 2011 08:30 ET
|
Neuronetics
MALVERN, PA--(Marketwire - May 9, 2011) - Neuronetics, Inc., maker of the NeuroStar Transcranial Magnetic Stimulation (TMS) Therapy® System, has been selected by TiE Silicon Valley as a 2011 recipient...
New Data Show No Negative Long-Term Effect in Cognitive Function in Patients With Major Depressive Disorder Treated With NeuroStar TMS Therapy(R)
April 14, 2011 13:30 ET
|
Neuronetics
HONOLULU, HI--(Marketwire - Apr 14, 2011) - In an open-label study of patients with major depressive disorder (MDD) who had not benefitted from prior antidepressant medication and were treated with...
Neuronetics Appoints Vice President of Health Policy and Government Relations
March 02, 2011 08:00 ET
|
Neuronetics
MALVERN, PA--(Marketwire - March 2, 2011) - Neuronetics, Inc. today announced that Mary Hailey, an industry executive with more than 25 years of experience in designing and implementing healthcare...